Oral Nano Vitamin D Supplementation Efficacy in Inflammatory Bowel Disease

Supplementation Efficacy Comparing the Oral Nano and Conventional Vitamin D in Inflammatory Bowel Disease

Status

UNKNOWN

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT05733117

Enrollment

120

Registered

2023-02-17

Start date

2022-10-25

Completion date

2024-01-01

Last updated

2023-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitamin D Substitution

Brief summary

The purpose of this study is to compare efficacy of the suplementation using the conventional oral and oral nano form of the calciferol.

Detailed description

Conventional oral vit D formulas have variable availability esp. in IBD patients. Oral nano vitamin D is absorbed in the mouth. The aim of this study is to compare the efficacy of both formulations by matching vitD levels after supplementation and to determine the equivalent dose.

Interventions

DRUGVitamin D

cholecalciferol

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 70 Years

Healthy volunteers

Inclusion criteria

* The inflammatory bowel disease patients

Exclusion criteria

* Liver and renal disease * Hypercalcemia * Hyperparathyreoidism * Chronic pancreatitis * Concomitant vitamin D medication * Pregnancy * Sarcoidosis * Malignancy * Inability to obtain valid data from subject

Design outcomes

Primary

Measure	Time frame	Description
Vitamin D (25OHD) blood level	4 months	Change of the D vitamin level after follow-up interval

Countries

Czechia

Contacts

Primary ContactVladimír Kojecký

kojecky@bnzlin.cz+420577552512

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026